Paloma Partners Management CO Bristol Myers Squibb CO Put Options Transaction History

Paloma Partners Management CO

11 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	BUY	$40.25 - $52.99 $2.14 Million - $2.82 Million	53,200 New	53,200 $2.21 Million
Q4 2023 Feb 14, 2024	SELL	$48.48 - $57.85 $7.15 Million - $8.53 Million	-147,500 Reduced 50.51%	144,500 $7.41 Million
Q3 2023 Nov 14, 2023	BUY	$57.89 - $64.73 $5.5 Million - $6.15 Million	95,000 Added 48.22%	292,000 $16.9 Million
Q2 2023 Aug 14, 2023	BUY	$63.71 - $70.74 $9.82 Million - $10.9 Million	154,200 Added 360.28%	197,000 $12.6 Million
Q1 2023 May 15, 2023	SELL	$65.71 - $74.53 $3.66 Million - $4.15 Million	-55,700 Reduced 56.55%	42,800 $2.97 Million
Q4 2022 Feb 14, 2023	BUY	$68.48 - $81.09 $6.75 Million - $7.99 Million	98,500 New	98,500 $7.09 Million
Q3 2019 Nov 14, 2019	BUY	$42.77 - $50.71 $1 Million - $1.19 Million	23,400 Added 508.7%	28,000 $1.42 Million
Q2 2019 Aug 14, 2019	SELL	$44.62 - $49.34 $1.79 Million - $1.98 Million	-40,100 Reduced 89.71%	4,600 $209,000
Q2 2018 Aug 14, 2018	SELL	$50.53 - $62.98 $2.84 Million - $3.54 Million	-56,200 Reduced 55.7%	44,700 $2.47 Million
Q4 2017 Feb 14, 2018	BUY	$59.94 - $65.35 $1.57 Million - $1.71 Million	26,200 Added 35.07%	100,900 $6.18 Million
Q3 2017 Nov 14, 2017	BUY	$55.23 - $63.74 $4.13 Million - $4.76 Million	74,700	74,700 $4.76 Million

2,533

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

Stay updated on Paloma Partners Management CO with notifications on news.